States Begin Detailing Specific Use of 150 Million BinaxNOW COVID-19 Tests Distributed by Trump Administration
HHS released preliminary data on states’ reported use of the 150 million Abbott rapid point-of-care (POC) SARS-CoV-2 diagnostic tests distributed by HHS beginning in late September. Per preliminary reports from states, allocations are largely being deployed to local health departments, K-12 schools and institutes of higher education, nursing homes, hospitals and correctional facilities. Of the 150 million test kits acquired by HHS, 100 million test kits are reserved for weekly shipments to Governors, who have discretion to allocate test kits as they see fit. The remaining 50 million tests are reserved for direct shipments to congregate care settings such as nursing homes, assisted living facilities, home health, hospice, the Indian Health Service, and historically black colleges and universities (HBCUs).